BioNTech SE (BNTX) Current Taxes (2018 - 2025)
BioNTech SE's (BNTX) quarterly Current Taxes came in at $76.4 million in Q4 2025, up 1487.99% year-on-year from $4.8 million in Q4 2024, and up 936.81% quarter-over-quarter from $7.4 million in Q3 2025.
BioNTech SE (BNTX) Current Taxes (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Current Taxes across 7 years of filings, most recently posting $76.4 million for Q4 2025.
- Current Taxes for Q4 2025 came in at $76.4 million, up 1487.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $76.4 million (up 1487.99% YoY), and the FY2025 annual result was $74.1 million, up 1441.29% from the prior year.
- Current Taxes came in at $76.4 million for Q4 2025 at BioNTech SE, up from $7.4 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $1.8 billion in Q1 2022 to a low of $4.2 million in Q2 2025.
- The 5-year median for Current Taxes is $565.2 million (2023), against an average of $629.2 million.
- Across the five-year window, Current Taxes slumped 99.15% in 2024 and jumped 1487.99% in 2025, its largest moves.
- BioNTech SE's Current Taxes stood at $1.8 billion in 2021, then slumped by 66.13% to $608.0 million in 2022, then fell by 7.0% to $565.4 million in 2023, then tumbled by 99.15% to $4.8 million in 2024, then soared by 1487.99% to $76.4 million in 2025.
- The last three Current Taxes figures came in at $76.4 million (Q4 2025), $7.4 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 76.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.36 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 4.19 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 399.31 Mn |
| Jun 30, 2024 | 393.28 Mn |
| Mar 31, 2024 | 383.70 Mn |
| Dec 31, 2023 | 565.41 Mn |
| Sep 30, 2023 | 593.50 Mn |
| Jun 30, 2023 | 604.24 Mn |
| Mar 31, 2023 | 564.90 Mn |
| Dec 31, 2022 | 607.97 Mn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.81 Bn |
| Dec 31, 2021 | 1.79 Bn |
| Mar 31, 2021 | 596.97 Mn |
| Dec 31, 2019 | 166,033.15 |
| Sep 30, 2019 | 330,480.82 |